XML 71 R44.htm IDEA: XBRL DOCUMENT
v3.25.4

Supplemental Financial Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Supplemental Balance Sheet Information [Abstract] |
Schedule of Cash and Cash Equivalents | The reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheet to the totals shown within the consolidated statements of cash flows is as follows (in thousands):
| As of December 31,
| 2025 |  | 2024 |  | 2023
Cash and cash equivalents | $ | 167,202 |  |  | $ | 561,572 |  |  | $ | 944,073 |
Restricted cash included in prepaid expenses and other current assets (1) | 7,031 |  |  | 5,839 |  |  | 4,789 |
Restricted cash included in other non-current assets (1) | 38,138 |  |  | 38,332 |  |  | 40,722 |
Total cash, cash equivalents and restricted cash | $ | 212,371 |  |  | $ | 605,743 |  |  | $ | 989,584 |
(1)Includes cash balances collateralizing letters of credit associated with the Company’s facility leases and customer prepayments requiring segregation and restrictions in its use in accordance with the customer agreement.
Restrictions on Cash and Cash Equivalents | The reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheet to the totals shown within the consolidated statements of cash flows is as follows (in thousands):
| As of December 31,
| 2025 |  | 2024 |  | 2023
Cash and cash equivalents | $ | 167,202 |  |  | $ | 561,572 |  |  | $ | 944,073 |
Restricted cash included in prepaid expenses and other current assets (1) | 7,031 |  |  | 5,839 |  |  | 4,789 |
Restricted cash included in other non-current assets (1) | 38,138 |  |  | 38,332 |  |  | 40,722 |
Total cash, cash equivalents and restricted cash | $ | 212,371 |  |  | $ | 605,743 |  |  | $ | 989,584 |
(1)Includes cash balances collateralizing letters of credit associated with the Company’s facility leases and customer prepayments requiring segregation and restrictions in its use in accordance with the customer agreement.
Schedule of Property, Plant and Equipment Net | Estimated lives of property, plant and equipment are as follows:
| Estimated Useful Life
Computer equipment and software | 2 to 5 years
Furniture and fixtures | 7 years
Lab equipment | 1 to 5 years
Buildings and facilities | 15 to 30 years
Vehicles | 5 years
Leasehold improvements | Shorter of useful life or remaining lease term
Property, plant and equipment, net consisted of the following (in thousands):
| As of December 31,
| 2025 |  | 2024
Lab equipment | $ | 146,279 |  |  | $ | 150,887 |
Leasehold improvements | 140,513 |  |  | 135,964 |
Buildings and facilities | 49,760 |  |  | 48,255 |
Construction in progress | 192 |  |  | 1,984 |
Computer equipment and software | 9,056 |  |  | 14,897 |
Furniture and fixtures | 6,520 |  |  | 6,545 |
Land | 6,060 |  |  | 6,060 |
Total property, plant, and equipment | 358,380 |  |  | 364,592 |
Less: Accumulated depreciation | (190,597) |  |  | (160,872) |
Property, plant and equipment, net | $ | 167,783 |  |  | $ | 203,720 |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands):
| As of December 31,
| 2025 |  | 2024
Operating lease liabilities | $ | 22,787 |  |  | $ | 28,630 |
Contractual shortfall liabilities (Note 12) | 15,919 |  |  | — |
Contingent consideration liability | 5,438 |  |  | 5,438 |
Biosecurity costs | 5,046 |  |  | 4,032 |
Employee compensation and benefits | 4,258 |  |  | 9,894 |
Professional fees and securities litigation costs | 4,378 |  |  | 2,167 |
External research and development expenses | 1,072 |  |  | 713 |
Deferred other income | 1,033 |  |  | 2,889 |
Employee termination costs | 816 |  |  | 2,387 |
Finance lease liabilities | 20 |  |  | 335 |
Property and equipment | — |  |  | 138 |
Other current liabilities | 5,691 |  |  | 8,764 |
Accrued expenses and other current liabilities | $ | 66,458 |  |  | $ | 65,387 |
Schedule of Operating Leases Supplemental Cash Flow Information | Supplemental cash flow information related to the Company’s operating leases were as follows (in thousands):
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |
Operating cash flows from operating leases | $ | 61,178 |  |  | $ | 45,019 |  |  | $ | 44,051 |
Operating cash flows from finance leases | 4 |  |  | 32 |  |  | 83 |
Financing cash flows from finance leases | 354 |  |  | 897 |  |  | 1,295 |
The following table presents supplemental cash flow information for each reporting period (in thousands):
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
Cash paid for interest | $ | 4 |  |  | $ | 32 |  |  | $ | 83 |
Cash paid for income taxes | 192 |  |  | 894 |  |  | 670 |
Non-cash investing and financing activities: |  |  |  |  |
ROU assets obtained in exchange for new operating lease liabilities | 336 |  |  | 223,853 |  |  | 27,668 |
Purchases of property and equipment included in accounts payable and accrued expenses | 46 |  |  | 2,565 |  |  | 2,915 |
Convertible financial instruments received for Cell Engineering services | — |  |  | — |  |  | 4,542 |
Equity securities and warrants received for Cell Engineering services | — |  |  | 55 |  |  | 17,450 |
Common stock issued for acquisitions | 777 |  |  | 18,245 |  |  | 6,820 |
Common stock issued as settlement of contingent consideration liabilities | — |  |  | 14,742 |  |  | 8,896 |
Common stock issued for retention payments related to business and asset acquisitions | — |  |  | 5,258 |  |  | — |
Return of investment in equity securities for reduction in deferred revenue | — |  |  | 6,760 |  |  | — |
Conversion of notes receivable for common stock | — |  |  | 10,476 |  |  | — |
Issuance costs related to ATM offering included in accounts payable and accrued expenses | 53 |  |  | — |  |  | — |
For the years ended December 31, 2025, the amount of cash income taxes paid by the Company was as follows (in thousands):
| Year Ended December 31,
| 2025
Federal | $ | — |
State and local: |
California | 12 |
South Carolina | 148 |
All other state and local | 32 |
Foreign | — |
Cash income taxes, net of refunds | $ | 192 |

X
- Definition Schedule of Accrued Expenses and Other Current Liabilities + References No definition available. + Details
Name: | dna_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock
Namespace Prefix: | dna_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Supplemental Balance Sheet Information [Abstract] + References No definition available. + Details
Name: | dna_SupplementalBalanceSheetInformationAbstract
Namespace Prefix: | dna_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 8 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration